The bcr-abl rearrangement in T-lineage ALL has been rarely described.
In the last three years we studied all new patients with ALL at diagno
sis by cytogenetic and molecular analysis. Three out of eleven T-linea
ge ALL patients presented the rearrangement and only one was Philadelp
hia positive.